Cardiology

The Endocrinology Network® Cardiology clinical resource center is a hub of news related to cardiovascular health that is relevant to clinicians interested in endocrinology. This page will host relevant content about cardiology and cardiovascular disease including guideline updates, new studies and breakthroughs, and clinical perspectives for practicing clinicians.

Blood Glucose at Admission Could Serve as Prognostic Marker in Emergency Departments

November 29, 2022

An analysis of data from patients admitted to emergency departments from 7 hospitals in Sweden provide insight into the potential of blood glucose at admission for use as a biomarker to predict all-cause mortality and cardiovascular risk in patients without a history of diabetes.

Co-Occuring Gestational Diabetes, Hypertension Linked with Doubling of Future Cardiovascular Risk

November 28, 2022

An analysis of more than 800k women in Canada provides insight into the apparent increase in risk of incident cardiovascular disease associated with co-occurrence of gestational diabetes and gestational hypertensive disorders in pregnant women.

Metformin Pulling Double Duty as Emerging Therapy in AFib, with Gregory Weiss, MD

November 05, 2022

In this column, Gregory Weiss, MD, provides perspective on a recent study providing evidence in support of metformin as a potential therapeutic option for treatment of atrial fibrillation.

T2D Diagnosis Before 40 Linked to More Than 5-fold Increase in Risk of All-Cause and Cardiovascular Mortality

September 07, 2022

A study presented at EASD 22 comparing 600k patients with type 2 diabetes against 1.2 million controls suggests a diagnosis of T2D prior to turning 40 was associated with a more than 5-fold increase in risk of mortality, heart failure hospitalization, and coronary heart disease.

Understanding Insulin Sensitivity, Adiposity, and Atherosclerosis, with Gregory Weiss, MD

September 05, 2022

In his most recent column, Dr. Gregory Weiss provides perspective on recent data elucidating the links between insulin sensitivity, central adiposity, and atherosclerosis.

Finerenone Reduces All-Cause Mortality, Sudden Cardiac Death in Type 2 Diabetes

August 29, 2022

An analysis of the FIDELITY program from ESC Congress 2022 details an 11% reduction in risk of all-cause mortality and a 25% reduction in risk of sudden cardiac death among patients with type 2 diabetes and chronic kidney disease.

NSAID Use Linked to Increased Heart Failure Risk in Type 2 Diabetes

August 23, 2022

An observational study of more than 300,000 with type 2 diabetes from Denmark suggests short-term use of NSAIDs was linked to a more than 40% increase in the likelihood of a first-time heart failure hospitalization.

Spotlighting Heart Failure Management in Diabetes at ADCES 2022

August 12, 2022

A presentation by Christine Schumacher, PharmD, and Elizabeth Van Dril, PharmD, at ADCES examines the current state of heart failure management in patients with diabetes.

Artificial Intelligence Tools Could Use ECGs to Predict Type 2, Prediabetes

August 10, 2022

Called the DiaBeats algorithm, new research suggests leveraging the machine learning-based algorithm, combined with ECG recordings, could help predict increased risk of developing prediabetes and type 2 diabetes.

GnRH Agonists for Prostate Cancer Could Increase CVD Risk in Type 2 Diabetes

August 09, 2022

New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.